Skip to main content
Toggle navigation
Login
Search
Home
Tweets by 2023 SSO Annual Meeting
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
PSM
Home
PSM
PSM
Type here to filter the list
E246: Development and External Validation of Prognostic Survival Nomograms for Appendiceal Mucinous Carcinoma Peritonei following Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy
Favorite
E247: Prognostic implications of a novel epigenetic signature of peritoneal metastasis in cell-free DNA (cfDNA) in patients with colorectal and high-grade appendiceal cancer undergoing optimal cytoreductive surgery
Favorite
E248: Optimizing Pain Management after Cytoreduction/Hyperthermic Intraperitoneal Chemoperfusion Shortens Hospital Stay and Decreases Opioid Use
Favorite
E249: Which Factors are Most Important in Predicting Disease-Free Survival following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Appendiceal and Colorectal Peritoneal Metastases?
Favorite
E250: Normal Carcinoembryonic Antigen Levels after Neoadjuvant Chemotherapy and Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion Predict Improved Survival from Colorectal Cancer with Carcinomatosis
Favorite
E251: Who should get Right Colectomy in Low-grade Appendiceal Adenocarcinomas? Association of Lymphovascular Invasion and Nodal Metastases
Favorite
E252: Peritoneal Mesothelioma: The importance of Facility Type
Favorite
E253: A Novel Ex-Vivo Human Tumor Model to Understand the Role of HIPEC in Peritoneal Malignancies
Favorite
E254: Histology-Driven Survival Differences After Iterative Cytoreductive Surgery and HIPEC
Favorite
E255: Impact of Preoperative Nutritional Status on Outcomes after Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy
Favorite
E256: Recurrence Patterns of Appendiceal Cancer after Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy
Favorite
E257: Risk Factors for Early versus Late Venous Thromboembolism after Cytoreductive Surgery and HIPEC
Favorite
E258: Risk Factors for Failure to Rescue Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Favorite
E259: Acute Kidney Injury Following CRS/HIPEC with High-Dose Cisplatin and Goal-Directed Intravenous Fluid Administration Strategy
Favorite
E260: Insight into Predictors of the Cytoreduction Score Following Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy for Gastric Peritoneal Carcinomatosis Improves Patient Selection and Prognostic Outcomes
Favorite
E261: Peritoneal Recurrence a Potential Surrogate Endpoint for Overall Survival in Cytoreductive Surgery/ Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) Clinical Trials
Favorite
E383: Metabolic Reprogramming with Glutamine Antagonism Enhances Anti-tumor Responses in Colorectal Peritoneal Metastasis.
Favorite
GPPO3: The Impact of Enhanced Recovery Protocol (ERAS) In Peritoneal Surface Malignancies Managed with Cytoreductive Surgery & Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicentric Collaboration
Favorite
P49: Convolutional Neural Network to Predict Peritoneal Carcinomatosis Risk in Gastric Cancer
Favorite
P50: Novel Vascularized Microtumor (VMT) Model of Peritoneal Carcinomatosis (PC) with Mesothelial-Lined Chambers and Submesothelial Stroma that Mimic the Peritoneal Cavity
Favorite
P51: Hyperthermic intraperitoneal chemotherapy restores physiologic tumor stiffness & stimulates lymphocyte proliferation & recruitment
Favorite
P52: Impact of Primary Tumor Location and Genomic Alterations on Survival Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Colorectal Peritoneal Metastases
Favorite
P53: Therapeutic Implications of Germline Testing in Peritoneal Mesothelioma
Favorite
P54: A comparative evaluation of efficacy endpoints in colorectal and appendiceal carcinomatosis treated with PIPAC: Secondary analysis of a US multicenter phase 1 trial
Favorite
P55: Defining Values and Quality of Life of Cancer Survivors following Cytoreductive Surgery and HIPEC: An International Study
Favorite
P56: A Data Driven Approach for Individualized Risk Prediction of Serious Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Favorite